This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
No quarterly split; consolidated half-year revenue Rs 3,737.34 lakh, net profit Rs 310.34 lakh
MEDISTEP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
On a consolidated unaudited basis, revenue for the half year ended 30 September 2026 was Rs 3,737.34 lakh, up 6.6%, versus Rs 3,506.88 lakh a year earlier, while profit after tax was Rs 310.34 lakh, up 4.5%, versus Rs 297.09 lakh; no quarterly figures are provided. Operating cash flow was positive at Rs 86.18 lakh, and borrowings of Rs 512.39 lakh were below equity of Rs 4,092.81 lakh. The auditor's limited review raised no concerns.
Mildly positive: half-year revenue and profit after tax rose, operating cash flow stayed positive, and borrowings are low compared with equity.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹37.37 Cr | ₹35.07 Cr | +6.6% |
| Operating profit | ₹4.18 Cr | ₹3.97 Cr | +5.4% |
| Profit after tax | ₹3.13 Cr | — | — |
| EBITDA margin | 11.8% | — | — |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.